![Patricia Ann Walicke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patricia Ann Walicke
No open positions remaining
Profile
Dr. Patricia A. Walicke is Head-Clinical Development at Dragonfly Sciences, Inc.
Dr. Walicke was previously employed as Chief Medical Officer & VP-Clinical Affairs by Oxigene, Inc., Vice President-Clinical & Regulatory Affairs by Avidia, Inc., Vice President-Clinical Development by Rinat Neuroscience Corp., Medical Director & Senior Clinical Scientist by Genentech, Inc., and Medical Director by Quintiles, Inc.
She received her undergraduate degree from the Massachusetts Institute of Technology, a doctorate degree from Harvard Medical School, and a doctorate degree from Harvard University.
Former positions of Patricia Ann Walicke
| Companies | Position | End |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2009-04-28 |
Avidia, Inc.
 Avidia, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Tech/Sci/R&D Officer | 2006-09-30 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Chief Tech/Sci/R&D Officer | 2005-09-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | 2003-09-30 |
Dragonfly Sciences, Inc.
 Dragonfly Sciences, Inc. BiotechnologyHealth Technology Develops biosimilar products of monoclonal antibodies and soluble receptors | Corporate Officer/Principal | - |
Training of Patricia Ann Walicke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dragonfly Sciences, Inc.
Dragonfly Sciences, Inc. BiotechnologyHealth Technology Develops biosimilar products of monoclonal antibodies and soluble receptors | Health Technology |
- Stock Market
- Insiders
- Patricia Ann Walicke
